Jala, Pika J.

HRN: 27-74-46  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/02/2025
CEFTRIAXONE 1G (VIAL)
09/02/2025
09/09/2025
IV
2g
OD
Possible PID
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines